Topline results expected in the third quarter of 2025. SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company ...
Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback